Role of the endothelium in the genesis of cardiovascular disease

Clinical and Experimental Pharmacology and Physiology

Volumn 23, Issue 8, 1996, Pages s16-s22

  Angus, James A ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Angiogenesis; Collateral vessels; Congestive heart failure; Endothelial dysfunction; Endothelium; Hypertension; Nitric oxide

Indexed keywords

ANIMAL; CARDIOVASCULAR DISEASE; CORONARY BLOOD VESSEL; DOG; HUMAN; HYPERTENSION; PATHOLOGY; PATHOPHYSIOLOGY; RABBIT; REVIEW; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; CONFERENCE PAPER; CONGESTIVE HEART FAILURE; ENDOTHELIUM; IN VITRO STUDY; IN VIVO STUDY; VASCULAR RESISTANCE;

ANIMALS; CARDIOVASCULAR DISEASES; CORONARY VESSELS; DOGS; ENDOTHELIUM, VASCULAR; HUMANS; HYPERTENSION; MUSCLE, SMOOTH, VASCULAR; RABBITS;

ACETYLCHOLINE; CHOLINERGIC RECEPTOR; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

EID: 0029968001     PISSN: 03051870     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1681.1996.tb03036.x     Document Type: Article

References (29)

1. Campbell WB, Gebremedhin D, Pratt PF, Harder DR. Identification of epoxyeicosatrienoic acids as endothelium-derived hyperpolarizing factors. Cire. Res. I996; 78: 415-23.
2. Fukao M, Hattori Y, Kanno M, Sakuma I, Kitabatake A. Evidence of selective inhibition of lysophosphatidylcholine of acetylcholineinduced endothelium-dependent hyperpolarisation and relaxation in rat mesenteric artery. Br. J. Pharmacol. 1995; 116: 1541-4.
3. Languie BL. Remodelling of developing and mature arteries: endothelium, smooth muscle and matrix. J. Cardiovasc. Pharmacol. 1993; 21 (Suppl. 1): SI 1-17.
4. Bassenge E. Control of coronary blood flow by autacoids. Basic Res. Cardiol. 1995; 90: 125-41.
5. Angus JA. Arteriolar structure and its implications for function in health and disease. Curr. Opin. Nephrol. Hypertens. 1994; 3: 99-106.
6. Furchgott RF, Zawadski JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288: 373-6.
7. Angus JA, Cocks TM. Endothelium-derived relaxing factor. Pharmacol. Ther. 1989; 41: 303-51.
8. Ludmer PL, Selwyn AP, Shook TL et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N. Engl. J. Med. 1986; 315: 1046-51.
9. Chowienczyk PJ, Cockcroft JR, Ritter JM. Inhibition of acetylcholinesterase selectively potentiates A-monomethyl-Larginine-resistant actions of acetylcholine in human forearm vasculature. Clin. Sci. 1995; 88: 111-17.
10. Chowienczyk PJ, Cockroft JR, Ritter JM. Blood flow responses to intra-arterial acetylcholine in man: Effects of basal flow conduit vessel length. Clin. Sci. 1994; 87: 45-51.
11. Chowienczyk PJ, Cockcroft JR, Ritter JM. Differential inhibition by NG-monomethyl-L-arginine of vasodilator effects of acetylcholine and methacholine in human forearm vasculature. Br. J. Pharmacol. 1993; 110: 736-8.
12. Angus JA, Dyke AC, Jennings GL et al. Release of endotheliumderived relaxing factor from resistance arteries in hypertension. Kidney Int. 1992; 41 (Suppl. 37): S73-8.
13. Angus JA, Broughton A, McPherson GA. Membrane potential and contractility responses to acetylcholine and other vasoconstrictor stimuli in human small coronary arteries. In: Mulvany MJ, Aalkajaer C, Heagerty AM, Nyborg NCB, Strandgaard S (eds). Resistance arteries, structure and function. Elsevier Science, Amsterdam. 1991; 255-60.
14. Konishi M, Su C. Role of endothelium in dilator responses of spontaneously hypertensive rat arteries. Hypertension 1983; 5: 881-6.
15. Winquist RJ, Bunting PB, Baskin EP, Wallace AA. Decreased endothelium-dependent relaxation in New Zealand genetic hypertensive rats. J. Hypertens. 1984; 2: 541-5.
16. Van de Voorde J, Leusen I. Endothelium-dependent and independent relaxation of aortic rings from hypertensive rats. Am. J. Physiol. 1986; 250: H71I-17.
17. Lockette W, Otsuka Y, Carretero O. The loss of endotheliumdependent vascular relaxation in hypertension. Hypertension 1986; 8 (Suppl. II):II61-6.
18. Angus JA, Lew MJ. Interpretation of the acetylcholine test of endothelial cell dysfunction in hypertension. J. Hypertens. 1992; 10 (Suppl. 7):S179-86.
19. Panza JA, Quyyumi AA, Brush JE, Epstein SE. Abnormal endo-thelium-dependent vascular relaxation in patients with essential hypertension, ff. Engl. J. Med. 1990; 323: 22-7.
20. Under L, Kiowski, Buhler FR, Luscher TF. Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo. Circulation 1990; 82: 1762-7.
21. Keim M, Preik M, Hafner DJ, Strauer BE. Evidence for a multifactorial process involved in the impaired flow response to nitric oxide in hypertensive patients with endothelial dysfunction. Hypertension 1996; 27: 346-53.
22. Cockcroft JR, Chowienczyk PJ, Benjamin N, Ritter JM. Preserved endothelium-dependent vasodilatation in patients with essential hypertension. N. Engl. J. Med. 1994; 330: 1036-40.
23. Wright CE, Angus JA, Korner PI. Vascular amplifier properties in renovascular hypertension in conscious rabbits. Hypertension 1987; 9: 122-31.
24. Angus JA, Femer CP, Sudhir K, Kaye DM, Jennings GL. Impaired contraction and relaxation in skin resistance arteries from patients with congestive heart failure. Cardiovasc. Res. 1993; 27: 204-10.
25. Zelis R, Hayoz D, Drexler H et al. Arterial dilatory reserve in congestive heart failure. J. Hypertens. 1992; 10 (Suppl): S65-7.
26. Speechly-Dick ME, Mocanu MM, Yellon DM. Protein kinase C, its role in ischémie preconditioning in the rat. Circ. Res. 1994; 75: 586-90.
27. Sobcy CG, Woodman OL. Myocardial ischaemia: What happens to the coronary arteries? Trends Pharmacol. Sci. 1993; 14:448-53.
28. Angus JA, Ward JE, Smolich JJ, McPherson GA. Reactivity of canine isolated epicardial collateral coronary arteries: Relation to vessel structure. Circ. Res. 1991; 69: 1340-52.
29. Ward JE, Angus JA. Collateral development and angiogenesis after major artery ligation does not alter hihdquarter vascular reactivity in conscious rabbits. J. Cardiovasc. Pharmacol. 1995; 26: 96-106.